A newly identified peptide, proadrenomedullin N-terminal 20 peptide, induces hypotensive action via pertussis toxin-sensitive mechanisms

Hypertension

Volumn 30, Issue 5, 1997, Pages 1009-1014

  Shimosawa, Tatsuo ^a   Ando, Katsuyuki ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Norepinephrine; Pertussis vaccine; Rats; Sympathetic nervous sytem

Indexed keywords

ADRENOMEDULLIN; GENE PRODUCT; PERTUSSIS TOXIN;

ADRENERGIC SYSTEM; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFECT; ENDOTHELIUM CELL; HYPOTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RAT;

EID: 0030699279     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1009     Document Type: Article

References (31)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192:553-560.
2. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun. 1994;201: 1160-1166.
3. Nuki C, Kawasaki H, Kitamura K, Takenaga M, Kangawa K, Eto T, Wada A. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun. 1993;196:245-251.
4. Ishizaka Y, Ishizaka Y, Tanaka M, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1994;200:642-646.
5. 2+ mobilization, in bovine aortic endothelial cells. J Biol Chem. 1995;270:4412-4417.
6. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun. 1993;194: 720-725.
7. Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, Matsuo H, Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun. 1993;195:921-927.
8. 2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J Clin Invest. 1995;96:1672-1676.
9. Shimosawa T, Fujita T. Hypotensive effect of newly identified peptide, proadrenomedullin N-terminal 20 peptide. Hypertension. 1996;28:325-329.
10. 2+ channels in evoked release of norepinephrine from sympathetic neurons. Science. 1988;239: 57-61.
11. Tsien R, Lipscombe D, Madison D, Bley K, Fox A. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 1988;11:431-438.
12. 2+ channel current through a pertussis toxin-sensitive G protein in rat pheochromocytoma-derived PC12 cells. J Clin Invest. 1996;98:14-17.
13. ia proteins and their messenger ribonucleic acids. Endocrinology. 1990;126:1295-1304.
14. Shimosawa T, Ando K, Ono A, Takahashi K, Isshiki M, Kanda M, Ogata E, Fujita T. Insulin inhibits norepinephrine overflow from peripheral sympathetic nerve ending. Biochem Biophys Res Commun. 1992;188:330-335.
15. Gillespie JS, Maclaren A, Pollock D. A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. Br J Pharmacol. 1970;40:257-267.
16. Ito Y, Noda H, Isaka M, Ando K, Sato Y, Fujita T. Norepinephrine responsiveness in patients with borderline hypertension under three different sodium balances. Clin Exp Hypertens A. 1989;1:363-370.
17. Ui M. The multiple biological activities of pertussis toxin. In: Wardlaw A, Parton R, eds. Pathogenesis and Immunity in Pertussis. New York, NY: John Wiley & Sons Ltd; 1988:121-145.
18. Kitamura K, Kangawa K, Ishiyama Y, Washimine H, Ichiki Y, Kawamoto M, Minamino N, Matsuo H, Eto T. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP). FEBS Lett. 1994;351:35-37.
19. Katoh F, Kitamura K, Niina H, Yamamoto R, Washimine H, Kangawa K, Yamamoto Y, Kobayashi H, Eto T, Wada A. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla. J Neurochem. 1995;64: 459-461.
20. Greene L, Tischler A. PC12 pheochromocytoma cultures in neurobiological research. Adv Cell Neurobiol. 1982;3:373-414.
21. Birnbaumer L. G-proteins in signal transduction. Annu Rev Pharmacol Toxicol. 1990;30:675-705.
22. Pfaffinger P, Martin J, Hunter D, Nathanson N, Hille B. GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature. 1985;317:536-538.
23. Taussig R, Sanchez S, Rifo M, Gilman AG, Belardetti F. Inhibition of the omega-conotoxin-sensitive calcium current by distinct G proteins. Neuron. 1992;8:799-809.
24. o transduces GABA B-receptor modulation of N-type calcium channels in cultured dorsal root ganglion neurons. Pflueg Arch Eur J Physiol. 1993;425: 335-343.
25. Diverse-Pierluissi M, Goldsmith PK, Dunlap K. Transmitter-mediated inhibition of N-type calcium channels in sensory neurons involves multiple GTP-binding proteins and subunits. Neuron. 1995; 14:191-200.
26. Washimine H, Kitamura K, Ichiki Y, Yamamoto Y, Kangawa K, Matsuo H, Eto T. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine. Biochem Biophys Res Commun. 1994;202:1081-1087.
27. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 1994; 338:6-10.
28. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem Biophys Res Commun. 1994;203: 719-726.
29. Caspi J, Coles JG, Benson LN, Herman SL, Act JA, Wilson GJ. Heart rate independence of catecholamine-induced myocardial damage in the newborn pig. Pediatr Res. 1994;36:49-54.
30. Rouleau JL, Packer M, Moye L, de Champlain J, Bichet D, Klein M, Rouleau JR, Sussex B, Arnold JM, Sestier F, Parker JO, McEwan P, Bernstein V, Cuddy TE, Lamas G, Gottlieb SS, McCans J, Nadeau C, Delage F, Wun CCC, Pfeffer MA. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol. 1994;24: 583-591.
31. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.